Summary of 2022 Case Studies
Last year, the R validation hub recently initiated a three-part presentation series on case studies in which eight pharmaceutical companies shared their experiences on building a GxP framework with R. These case studies highlighted both easy and challenging aspects of implementing risk assessment for R packages in a GxP environment. In this blog post we attempt to summarize common themes, difference in approaches, and challenges. All implementations followed the risk validation process for R packages outlined in the white paper.
